Verilumia 
Novartis Stock Rises on Positive MS Drug Trial Results
Novartis shares surged on Tuesday after the Swiss pharmaceutical company announced positive results from two late-stage clinical trials of its oral multiple sclerosis drug, remibrutinib, showing it outperformed a riva...
